PillOTC · Tablet, Coated · Oral
Ranitidine
Ranitidine Hydrochloride
1 ACTIVE SUPPLIER — US
openFDA · updated weekly
US1 NDCs
1 active makers
1 active makers
UKComing
soon
soon
CAComing
soon
soon
AUComing
soon
soon
EUComing
soon
soon
Medicaid dispensing volume
No Medicaid utilization on record for this drug concept yet. Quarterly volume (CMS State Drug Utilization Data) loads with the utilization ETL.
Who makes it1 active · 0 exited
US labelers as registered with FDA. Repackagers relabel another company's product; share* is of listed packages, not sales.
| Labeler | Type | Packages | Status |
|---|---|---|---|
| Dr.Reddy's laboratories Limited | unknown | 14 | SUPPLYING |
Regulatory & supply eventsFDA · US
Shortages, recalls, and registration changes attached to this drug concept.
- Oct 1, 2019RECALLRecall (Class II): Dr. Reddy's Ranitidine Tablets, USP 150 mg, 24 count bottles, NDC 55111-404-34 (OTC)
CGMP Deviations: Presence of NDMA impurity detected in product. — Recalling firm: Dr. Reddy's Laboratories, Inc. — Product was distributed to major distributors throughout the United States who may have further distributed the product.